NIH-funded research Fellowship grant

Understanding how serotonin receptor 7 affects immune tolerance in the gut

Official title: Identifying the role of serotonin receptor 7 in regulating intestinal immune tolerance

Funded at University of California Los Angeles · NIH-10826770 · Data updated 2026-11-12

This study is looking at how a specific serotonin receptor in the gut helps keep our immune system balanced and healthy by working with certain gut bacteria, which could lead to new ways to improve gut health and treat digestive issues.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$44,646
NIH project number1F31AI174799-01A1
Project IDNIH-10826770 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with gastrointestinal disorders or those interested in the relationship between gut microbiota and immune health.

Less likely to help

Patients with non-gastrointestinal related health issues may not receive direct benefits from this research.

What this research studies

This research investigates the role of serotonin receptor 7 in the gut's immune system, focusing on how it helps maintain a healthy balance between the host and gut microbiota. By examining the interactions between specific gut microbes, like Bacteroides fragilis, and immune cells, the study aims to uncover the molecular mechanisms that promote immune tolerance. Patients may benefit from insights into how gut health influences overall immune function and could lead to new therapeutic strategies for gastrointestinal disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for conditions related to gut health and immune responses.

How similar studies have gone: Previous research has shown promising results in understanding gut microbiota interactions and immune tolerance, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Yu, Lewis — University of California Los Angeles
  • Study coordinator: Yu, Lewis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.